Proliferative Diabetic Retinopathy Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Proliferative Diabetic Retinopathy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Anti-VEGF Agents
1.2.3 Corticosteroids
1.3 Market by Application
1.3.1 Global Proliferative Diabetic Retinopathy Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Proliferative Diabetic Retinopathy Market Perspective (2017-2028)
2.2 Proliferative Diabetic Retinopathy Growth Trends by Region
2.2.1 Proliferative Diabetic Retinopathy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Proliferative Diabetic Retinopathy Historic Market Size by Region (2017-2022)
2.2.3 Proliferative Diabetic Retinopathy Forecasted Market Size by Region (2023-2028)
2.3 Proliferative Diabetic Retinopathy Market Dynamics
2.3.1 Proliferative Diabetic Retinopathy Industry Trends
2.3.2 Proliferative Diabetic Retinopathy Market Drivers
2.3.3 Proliferative Diabetic Retinopathy Market Challenges
2.3.4 Proliferative Diabetic Retinopathy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Proliferative Diabetic Retinopathy Players by Revenue
3.1.1 Global Top Proliferative Diabetic Retinopathy Players by Revenue (2017-2022)
3.1.2 Global Proliferative Diabetic Retinopathy Revenue Market Share by Players (2017-2022)
3.2 Global Proliferative Diabetic Retinopathy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Proliferative Diabetic Retinopathy Revenue
3.4 Global Proliferative Diabetic Retinopathy Market Concentration Ratio
3.4.1 Global Proliferative Diabetic Retinopathy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Proliferative Diabetic Retinopathy Revenue in 2021
3.5 Proliferative Diabetic Retinopathy Key Players Head office and Area Served
3.6 Key Players Proliferative Diabetic Retinopathy Product Solution and Service
3.7 Date of Enter into Proliferative Diabetic Retinopathy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Proliferative Diabetic Retinopathy Breakdown Data by Type
4.1 Global Proliferative Diabetic Retinopathy Historic Market Size by Type (2017-2022)
4.2 Global Proliferative Diabetic Retinopathy Forecasted Market Size by Type (2023-2028)
5 Proliferative Diabetic Retinopathy Breakdown Data by Application
5.1 Global Proliferative Diabetic Retinopathy Historic Market Size by Application (2017-2022)
5.2 Global Proliferative Diabetic Retinopathy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Proliferative Diabetic Retinopathy Market Size (2017-2028)
6.2 North America Proliferative Diabetic Retinopathy Market Size by Country (2017-2022)
6.3 North America Proliferative Diabetic Retinopathy Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Proliferative Diabetic Retinopathy Market Size (2017-2028)
7.2 Europe Proliferative Diabetic Retinopathy Market Size by Country (2017-2022)
7.3 Europe Proliferative Diabetic Retinopathy Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Proliferative Diabetic Retinopathy Market Size (2017-2028)
8.2 Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Country (2017-2022)
8.3 Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Proliferative Diabetic Retinopathy Market Size (2017-2028)
9.2 Latin America Proliferative Diabetic Retinopathy Market Size by Country (2017-2022)
9.3 Latin America Proliferative Diabetic Retinopathy Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Proliferative Diabetic Retinopathy Market Size (2017-2028)
10.2 Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Country (2017-2022)
10.3 Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Intas Pharmaceuticals
11.1.1 Intas Pharmaceuticals Company Detail
11.1.2 Intas Pharmaceuticals Business Overview
11.1.3 Intas Pharmaceuticals Proliferative Diabetic Retinopathy Introduction
11.1.4 Intas Pharmaceuticals Revenue in Proliferative Diabetic Retinopathy Business (2017-2022)
11.1.5 Intas Pharmaceuticals Recent Development
11.2 Santen Pharmaceutical
11.2.1 Santen Pharmaceutical Company Detail
11.2.2 Santen Pharmaceutical Business Overview
11.2.3 Santen Pharmaceutical Proliferative Diabetic Retinopathy Introduction
11.2.4 Santen Pharmaceutical Revenue in Proliferative Diabetic Retinopathy Business (2017-2022)
11.2.5 Santen Pharmaceutical Recent Development
11.3 Bausch Health
11.3.1 Bausch Health Company Detail
11.3.2 Bausch Health Business Overview
11.3.3 Bausch Health Proliferative Diabetic Retinopathy Introduction
11.3.4 Bausch Health Revenue in Proliferative Diabetic Retinopathy Business (2017-2022)
11.3.5 Bausch Health Recent Development
11.4 Allergan Plc
11.4.1 Allergan Plc Company Detail
11.4.2 Allergan Plc Business Overview
11.4.3 Allergan Plc Proliferative Diabetic Retinopathy Introduction
11.4.4 Allergan Plc Revenue in Proliferative Diabetic Retinopathy Business (2017-2022)
11.4.5 Allergan Plc Recent Development
11.5 Regeneron Pharmaceuticals
11.5.1 Regeneron Pharmaceuticals Company Detail
11.5.2 Regeneron Pharmaceuticals Business Overview
11.5.3 Regeneron Pharmaceuticals Proliferative Diabetic Retinopathy Introduction
11.5.4 Regeneron Pharmaceuticals Revenue in Proliferative Diabetic Retinopathy Business (2017-2022)
11.5.5 Regeneron Pharmaceuticals Recent Development
11.6 Merck KGaA
11.6.1 Merck KGaA Company Detail
11.6.2 Merck KGaA Business Overview
11.6.3 Merck KGaA Proliferative Diabetic Retinopathy Introduction
11.6.4 Merck KGaA Revenue in Proliferative Diabetic Retinopathy Business (2017-2022)
11.6.5 Merck KGaA Recent Development
11.7 Cipla
11.7.1 Cipla Company Detail
11.7.2 Cipla Business Overview
11.7.3 Cipla Proliferative Diabetic Retinopathy Introduction
11.7.4 Cipla Revenue in Proliferative Diabetic Retinopathy Business (2017-2022)
11.7.5 Cipla Recent Development
11.8 Genentech, Inc. (Roche Holdings)
11.8.1 Genentech, Inc. (Roche Holdings) Company Detail
11.8.2 Genentech, Inc. (Roche Holdings) Business Overview
11.8.3 Genentech, Inc. (Roche Holdings) Proliferative Diabetic Retinopathy Introduction
11.8.4 Genentech, Inc. (Roche Holdings) Revenue in Proliferative Diabetic Retinopathy Business (2017-2022)
11.8.5 Genentech, Inc. (Roche Holdings) Recent Development
11.9 Novartis
11.9.1 Novartis Company Detail
11.9.2 Novartis Business Overview
11.9.3 Novartis Proliferative Diabetic Retinopathy Introduction
11.9.4 Novartis Revenue in Proliferative Diabetic Retinopathy Business (2017-2022)
11.9.5 Novartis Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Detail
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Proliferative Diabetic Retinopathy Introduction
11.10.4 Pfizer Revenue in Proliferative Diabetic Retinopathy Business (2017-2022)
11.10.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Proliferative Diabetic Retinopathy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Anti-VEGF Agents
Table 3. Key Players of Corticosteroids
Table 4. Global Proliferative Diabetic Retinopathy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Proliferative Diabetic Retinopathy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Proliferative Diabetic Retinopathy Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Proliferative Diabetic Retinopathy Market Share by Region (2017-2022)
Table 8. Global Proliferative Diabetic Retinopathy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Proliferative Diabetic Retinopathy Market Share by Region (2023-2028)
Table 10. Proliferative Diabetic Retinopathy Market Trends
Table 11. Proliferative Diabetic Retinopathy Market Drivers
Table 12. Proliferative Diabetic Retinopathy Market Challenges
Table 13. Proliferative Diabetic Retinopathy Market Restraints
Table 14. Global Proliferative Diabetic Retinopathy Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Proliferative Diabetic Retinopathy Market Share by Players (2017-2022)
Table 16. Global Top Proliferative Diabetic Retinopathy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Proliferative Diabetic Retinopathy as of 2021)
Table 17. Ranking of Global Top Proliferative Diabetic Retinopathy Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Proliferative Diabetic Retinopathy Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Proliferative Diabetic Retinopathy Product Solution and Service
Table 21. Date of Enter into Proliferative Diabetic Retinopathy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Proliferative Diabetic Retinopathy Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Proliferative Diabetic Retinopathy Revenue Market Share by Type (2017-2022)
Table 25. Global Proliferative Diabetic Retinopathy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Proliferative Diabetic Retinopathy Revenue Market Share by Type (2023-2028)
Table 27. Global Proliferative Diabetic Retinopathy Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Proliferative Diabetic Retinopathy Revenue Market Share by Application (2017-2022)
Table 29. Global Proliferative Diabetic Retinopathy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Proliferative Diabetic Retinopathy Revenue Market Share by Application (2023-2028)
Table 31. North America Proliferative Diabetic Retinopathy Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Proliferative Diabetic Retinopathy Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Proliferative Diabetic Retinopathy Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Proliferative Diabetic Retinopathy Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Proliferative Diabetic Retinopathy Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Proliferative Diabetic Retinopathy Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Proliferative Diabetic Retinopathy Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Proliferative Diabetic Retinopathy Market Size by Country (2023-2028) & (US$ Million)
Table 41. Intas Pharmaceuticals Company Detail
Table 42. Intas Pharmaceuticals Business Overview
Table 43. Intas Pharmaceuticals Proliferative Diabetic Retinopathy Product
Table 44. Intas Pharmaceuticals Revenue in Proliferative Diabetic Retinopathy Business (2017-2022) & (US$ Million)
Table 45. Intas Pharmaceuticals Recent Development
Table 46. Santen Pharmaceutical Company Detail
Table 47. Santen Pharmaceutical Business Overview
Table 48. Santen Pharmaceutical Proliferative Diabetic Retinopathy Product
Table 49. Santen Pharmaceutical Revenue in Proliferative Diabetic Retinopathy Business (2017-2022) & (US$ Million)
Table 50. Santen Pharmaceutical Recent Development
Table 51. Bausch Health Company Detail
Table 52. Bausch Health Business Overview
Table 53. Bausch Health Proliferative Diabetic Retinopathy Product
Table 54. Bausch Health Revenue in Proliferative Diabetic Retinopathy Business (2017-2022) & (US$ Million)
Table 55. Bausch Health Recent Development
Table 56. Allergan Plc Company Detail
Table 57. Allergan Plc Business Overview
Table 58. Allergan Plc Proliferative Diabetic Retinopathy Product
Table 59. Allergan Plc Revenue in Proliferative Diabetic Retinopathy Business (2017-2022) & (US$ Million)
Table 60. Allergan Plc Recent Development
Table 61. Regeneron Pharmaceuticals Company Detail
Table 62. Regeneron Pharmaceuticals Business Overview
Table 63. Regeneron Pharmaceuticals Proliferative Diabetic Retinopathy Product
Table 64. Regeneron Pharmaceuticals Revenue in Proliferative Diabetic Retinopathy Business (2017-2022) & (US$ Million)
Table 65. Regeneron Pharmaceuticals Recent Development
Table 66. Merck KGaA Company Detail
Table 67. Merck KGaA Business Overview
Table 68. Merck KGaA Proliferative Diabetic Retinopathy Product
Table 69. Merck KGaA Revenue in Proliferative Diabetic Retinopathy Business (2017-2022) & (US$ Million)
Table 70. Merck KGaA Recent Development
Table 71. Cipla Company Detail
Table 72. Cipla Business Overview
Table 73. Cipla Proliferative Diabetic Retinopathy Product
Table 74. Cipla Revenue in Proliferative Diabetic Retinopathy Business (2017-2022) & (US$ Million)
Table 75. Cipla Recent Development
Table 76. Genentech, Inc. (Roche Holdings) Company Detail
Table 77. Genentech, Inc. (Roche Holdings) Business Overview
Table 78. Genentech, Inc. (Roche Holdings) Proliferative Diabetic Retinopathy Product
Table 79. Genentech, Inc. (Roche Holdings) Revenue in Proliferative Diabetic Retinopathy Business (2017-2022) & (US$ Million)
Table 80. Genentech, Inc. (Roche Holdings) Recent Development
Table 81. Novartis Company Detail
Table 82. Novartis Business Overview
Table 83. Novartis Proliferative Diabetic Retinopathy Product
Table 84. Novartis Revenue in Proliferative Diabetic Retinopathy Business (2017-2022) & (US$ Million)
Table 85. Novartis Recent Development
Table 86. Pfizer Company Detail
Table 87. Pfizer Business Overview
Table 88. Pfizer Proliferative Diabetic Retinopathy Product
Table 89. Pfizer Revenue in Proliferative Diabetic Retinopathy Business (2017-2022) & (US$ Million)
Table 90. Pfizer Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Proliferative Diabetic Retinopathy Market Share by Type: 2021 VS 2028
Figure 2. Anti-VEGF Agents Features
Figure 3. Corticosteroids Features
Figure 4. Global Proliferative Diabetic Retinopathy Market Share by Application in 2021 & 2028
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Others Case Studies
Figure 8. Proliferative Diabetic Retinopathy Report Years Considered
Figure 9. Global Proliferative Diabetic Retinopathy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Proliferative Diabetic Retinopathy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Proliferative Diabetic Retinopathy Market Share by Region: 2021 VS 2028
Figure 12. Global Proliferative Diabetic Retinopathy Market Share by Players in 2021
Figure 13. Global Top Proliferative Diabetic Retinopathy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Proliferative Diabetic Retinopathy as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Proliferative Diabetic Retinopathy Revenue in 2021
Figure 15. North America Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Proliferative Diabetic Retinopathy Market Share by Country (2017-2028)
Figure 17. United States Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Proliferative Diabetic Retinopathy Market Share by Country (2017-2028)
Figure 21. Germany Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Proliferative Diabetic Retinopathy Market Share by Region (2017-2028)
Figure 29. China Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Proliferative Diabetic Retinopathy Market Share by Country (2017-2028)
Figure 37. Mexico Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Proliferative Diabetic Retinopathy Market Share by Country (2017-2028)
Figure 41. Turkey Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Proliferative Diabetic Retinopathy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Intas Pharmaceuticals Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2017-2022)
Figure 44. Santen Pharmaceutical Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2017-2022)
Figure 45. Bausch Health Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2017-2022)
Figure 46. Allergan Plc Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2017-2022)
Figure 47. Regeneron Pharmaceuticals Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2017-2022)
Figure 48. Merck KGaA Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2017-2022)
Figure 49. Cipla Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2017-2022)
Figure 50. Genentech, Inc. (Roche Holdings) Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2017-2022)
Figure 51. Novartis Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2017-2022)
Figure 52. Pfizer Revenue Growth Rate in Proliferative Diabetic Retinopathy Business (2017-2022)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Industry Market Size
